[Significant Events]

Herbs Generation Group Holdings Limited (02593) will launch an IPO from December 11 to December 16, planning to globally offer 33.3336 million shares.

Peking Autos (01958): Beiqi Investment and Hyundai Motor jointly invested approximately 1.095 billion US dollars in Beijing Hyundai.

SenseTime (00020) plans to place 1.865 billion Class B shares, raising approximately 2.787 billion Hong Kong dollars.

Suoteng Juchuang (02498) plans to allocate up to 10 million new shares, raising approximately 0.271 billion HKD.

GRANDPHARMA (00512) has reached a strategic cooperation agreement with Jixing for product introduction, obtaining exclusive development and commercialization rights for the world's first innovative product for treating dry eye syndrome.

The breast cancer treatment drug "Alectinib Injection" developed by SINO BIOPHARM (01177) has been approved for market.

DALIPAL HLDG (01921) has passed the compliance management system certification by the United Kingdom Standard Association.

[Earnings Reports Data]

Kanzhun-W (02076) achieved a historic quarterly net profit high in the third quarter, reaching 0.464 billion yuan, an 8.9% increase year-on-year.

China Pacific Insurance (02601): The Pacific Life Insurance accumulated original premium income of 228.842 billion yuan in the first 11 months, a year-on-year increase of 2.2%.

CGN NEW ENERGY (01811) completed a power generation of 1,360.8 GWh in November, a year-on-year decrease of 18%.

For more details, please refer to 智通财经网().